About Triptorelin
Triptorelin is a synthetic decapeptide agonist analogue of gonadotropin-releasing hormone (GnRH) used in reproductive endocrinology research. Supplied as a lyophilized powder for laboratory investigations into gonadotropin signaling and hypothalamic-pituitary-gonadal axis pathway markers. Each batch undergoes analytical verification for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Is there a difference in ovarian hyperstimulation syndrome rates in freeze-all treatment cycles in high-risk patients treated with different GnRH agonist triggers?
Recent research on Triptorelin: Is there a difference in ovarian hyperstimulation syndrome rates in freeze-all treatment cycles in high-risk patients treated with different GnRH agonist triggers?
Read Full Study on PubMedEvaluation of triplet therapy combined with robot-assisted cytoreductive prostatectomy for high-volume metastatic prostate cancer: a multicentre randomised controlled trial protocol.
Recent research on Triptorelin: Evaluation of triplet therapy combined with robot-assisted cytoreductive prostatectomy for high-volume metastatic prostate cancer: a multicentre randomised controlled trial protocol.
Read Full Study on PubMedAdditional Studies
Optimizing ovarian stimulation in oocyte donation: exploratory comparison of rhFSH (2:1) versus hp-hMG under PPOS protocols.
Recent research on Triptorelin: Optimizing ovarian stimulation in oocyte donation: exploratory comparison of rhFSH (2:1) versus hp-hMG under PPOS protocols.
Read on PubMedThe two-shot protocol. A randomized controlled trial of a novel two-injection ovarian stimulation strategy.
Recent research on Triptorelin: The two-shot protocol. A randomized controlled trial of a novel two-injection ovarian stimulation strategy.
Read on PubMedSterile abscesses during GnRH agonist therapy for central precocious puberty: a case series and literature review.
Recent research on Triptorelin: Sterile abscesses during GnRH agonist therapy for central precocious puberty: a case series and literature review.
Read on PubMedPubertal Triptorelin Exposure Alters Hypothalamic Reproductive-Metabolic Integration in a Sex-Specific Manner.
Recent research on Triptorelin: Pubertal Triptorelin Exposure Alters Hypothalamic Reproductive-Metabolic Integration in a Sex-Specific Manner.
Read on PubMedDevelopment of a parsimonious predictive model for height gain outcome in children with central precocious puberty following gonadotropin-releasing hormone agonist therapy.
Recent research on Triptorelin: Development of a parsimonious predictive model for height gain outcome in children with central precocious puberty following gonadotropin-releasing hormone agonist therapy.
Read on PubMedIn vitro fertilization-frozen embryo transfer in a patient with gonadotroph adenoma: Exacerbation of ovarian hyperstimulation by triptorelin: a case report.
Recent research on Triptorelin: In vitro fertilization-frozen embryo transfer in a patient with gonadotroph adenoma: Exacerbation of ovarian hyperstimulation by triptorelin: a case report.
Read on PubMedRelated Research
Purchase Triptorelin from Origin Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.